FDA to Accept De-Identified Real-World Evidence for Select Medical Device Applications | AJMC

FDA to Accept De-Identified Real-World Evidence for Select Medical Device Applications | AJMC

The FDA now accepts real-world evidence for medical device submissions without requiring identifiable patient data. This removes previous barriers, allowing the use of large, de-identified datasets that were previously inaccessible for regulatory review. Consequently, researchers can now leverage massive sources like hospital networks and insurance claims. This shift addresses the stagnation in RWE-supported approvals by expanding the pool of eligible evidence, potentially accelerating the evaluation of new medical technologies. This development is crucial for open data initiatives, as it legitimizes the use of aggregated, privacy-safe information in high-stakes regulatory decisions. It encourages broader data sharing and proves that valuable insights can be derived without compromising individual patient privacy.

Related news

• FDA removes patient-identifiable RWE requirement for device submissions
• First multimodal medical dataset launched to capture patient-clinician interactions
• Industry Powered by Your Identity – De-Anonymization Tech Overtaking the Pseudonym Age - CU Independent
• The Bureau of Labor Statistics published new employment data. Here's how unemployment and job growth looked in November.
• Ocultan información penales estatales sobre custodios